Data as of Dec 11
| -0.16 / -0.42%|
The 7 analysts offering 12-month price forecasts for ArthroCare Corp have a median target of 45.00, with a high estimate of 48.00 and a low estimate of 38.00. The median estimate represents a +17.22% increase from the last price of 38.39.
The current consensus among 8 polled investment analysts is to Buy stock in ArthroCare Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.